Dashboard
Manage Tickers

LH LABCORP HOLDINGS INC.

NYSE labcorp.com


$ 257.87 $ 3.88 (1.53 %)    

Monday, 03-Nov-2025 15:59:59 EST
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 629.78 $ -3.11 (-0.49 %)
DIA $ 472.70 $ -2.66 (-0.56 %)
SPY $ 681.88 $ -2.29 (-0.33 %)
TLT $ 89.68 $ 0.07 (0.08 %)
GLD $ 366.72 $ 0.05 (0.01 %)
$ 257.84
$ 253.00
$ 257.70 x 4
$ 261.77 x 4
-- - --
$ 208.23 - $ 293.72
1,008,991
na
22.82B
$ 0.67
$ 26.68
TBD
na
na ($ 0.01)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 10-31-2025 09-30-2025 10-Q
2 08-01-2025 06-30-2025 10-Q
3 04-29-2025 03-31-2025 10-Q
4 02-25-2025 12-31-2024 10-K
5 10-29-2024 09-30-2024 10-Q
6 08-02-2024 06-30-2024 10-Q
7 04-30-2024 03-31-2024 10-Q
8 02-26-2024 12-31-2023 10-K
9 10-30-2023 09-30-2023 10-Q
10 08-04-2023 06-30-2023 10-Q
11 05-04-2023 03-31-2023 10-Q
12 02-28-2023 12-31-2022 10-K
13 11-01-2022 09-30-2022 10-Q
14 08-01-2022 06-30-2022 10-Q
15 04-29-2022 03-31-2022 10-Q
16 02-25-2022 12-31-2021 10-K
17 11-02-2021 09-30-2021 10-Q
18 08-05-2021 06-30-2021 10-Q
19 05-04-2021 03-31-2021 10-Q
20 02-25-2021 12-31-2020 10-K
21 10-29-2020 09-30-2020 10-Q
22 07-31-2020 06-30-2020 10-Q
23 05-08-2020 03-31-2020 10-Q
24 02-28-2020 12-31-2019 10-K
25 10-31-2019 09-30-2019 10-Q
26 08-08-2019 06-30-2019 10-Q
27 05-03-2019 03-31-2019 10-Q
28 02-28-2019 12-31-2018 10-K
29 10-30-2018 09-30-2018 10-Q
30 07-27-2018 06-30-2018 10-Q
31 05-01-2018 03-31-2018 10-Q
32 02-27-2018 12-31-2017 10-K
33 11-02-2017 09-30-2017 10-Q
34 08-02-2017 06-30-2017 10-Q
35 04-28-2017 03-31-2017 10-Q
36 02-27-2017 12-31-2016 10-K
37 10-28-2016 09-30-2016 10-Q
38 07-29-2016 06-30-2016 10-Q
39 05-06-2016 03-31-2016 10-Q
40 02-29-2016 12-31-2015 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

ubs-maintains-buy-on-labcorp-hldgs-lowers-price-target-to-320
UBS Maintains Buy on Labcorp Hldgs, Lowers...
10/29/2025 17:38:58

UBS analyst Kevin Caliendo maintains Labcorp Hldgs (NYSE:LH) with a Buy and lowers the price target from $325 to $320.

labcorp-positioned-for-gradual-upside-with-resilient-margins-and-dividend-support
Labcorp Positioned For Gradual Upside With...
10/28/2025 18:45:54

Labcorp posts Q3 EPS of $4.18 and sales of $3.56 billion, exceeding estimates, while revising 2025 guidance amid strong diagnos...

nasdaq-100-hits-26000-gold-falls-below-4000-whats-moving-markets-tuesday
Nasdaq 100 Hits 26,000, Gold Falls Below $...
10/28/2025 17:23:51

Tech stocks hit new highs as the Nasdaq 100 rallies 0.7% midday. Investors eye a Fed rate cut, Trump-Xi meeting, and major tech...

earnings-scheduled-for-october-28-2025
Earnings Scheduled For October 28, 2025
10/28/2025 11:11:34

labcorp-hldgs-raises-fy2025-adj-eps-guidance-from-1605-1650-to-1615-1650-vs-1632-est-lowers-fy2025-sales-guidance-from-14080b-14230b-to-13973b-14051b-vs-14008b-est
Labcorp Hldgs Raises FY2025 Adj EPS Guidan...
10/28/2025 10:53:23

Labcorp Hldgs (NYSE:LH) raises FY2025 Adj EPS guidance from $16.05-$16.50 to $16.15-$16.50 vs $16.32 analyst estimate. Lowers F...

laboratory-corp-q3-adj-eps-418-beats-413-estimate-sales-3564b-beat-3559b-estimate
Laboratory Corp Q3 Adj. EPS $4.18 Beats $4...
10/28/2025 10:52:11

Laboratory Corp (NYSE:LH) reported quarterly earnings of $4.18 per share which beat the analyst consensus estimate of $4.13 by ...

labcorp-to-offer-first-fda-cleared-blood-test-in-primary-care-to-rule-out-alzheimers-related-amyloid-pathology-nationwide-availability-of-roches-elecsys-ptau181-by-early-2026
Labcorp To Offer First FDA-Cleared Blood T...
10/23/2025 11:11:29

ubs-maintains-buy-on-labcorp-hldgs-raises-price-target-to-325
UBS Maintains Buy on Labcorp Hldgs, Raises...
10/17/2025 13:55:33

UBS analyst Kevin Caliendo maintains Labcorp Hldgs (NYSE:LH) with a Buy and raises the price target from $305 to $325.

mizuho-maintains-outperform-on-labcorp-hldgs-raises-price-target-to-320
Mizuho Maintains Outperform on Labcorp Hld...
10/17/2025 13:22:37

Mizuho analyst Ann Hynes maintains Labcorp Hldgs (NYSE:LH) with a Outperform and raises the price target from $285 to $320.

if-you-invested-100-in-labcorp-hldgs-stock-20-years-ago-you-would-have-this-much-today
If You Invested $100 In Labcorp Hldgs Stoc...
10/15/2025 16:15:58

whats-driving-the-market-sentiment-around-labcorp-holdings-inc
What's Driving the Market Sentiment Around...
10/08/2025 15:00:51

evercore-isi-group-maintains-outperform-on-labcorp-hldgs-raises-price-target-to-305
Evercore ISI Group Maintains Outperform on...
10/03/2025 16:09:53

Evercore ISI Group analyst Elizabeth Anderson maintains Labcorp Hldgs (NYSE:LH) with a Outperform and raises the price targe...

what-analysts-are-saying-about-labcorp-hldgs-stock
What Analysts Are Saying About Labcorp Hld...
10/02/2025 18:01:46

labcorp-teams-up-with-roche-to-bring-digital-pathology-scanners-to-us-labs-adopts-new-digital-imaging-tech-to-improve-cancer-and-disease-diagnoses
Labcorp Teams Up With Roche To Bring Digit...
09/30/2025 11:07:28

Labcorp (NYSE:LH), a global leader of innovative and comprehensive laboratory services, announced today a collaboration with Ro...

how-do-investors-really-feel-about-labcorp-hldgs
How Do Investors Really Feel About Labcorp...
08/20/2025 13:00:38

heres-how-much-100-invested-in-labcorp-hldgs-20-years-ago-would-be-worth-today
Here's How Much $100 Invested In Labcorp H...
08/19/2025 22:30:22

labcorp-announced-the-availability-of-lumipulse-ptau-217beta-amyloid-42-ratio-first-blood-based-in-vitro-diagnostic-test-cleared-by-fda-for-diagnosis-of-alzheimers-disease
Labcorp Announced The Availability Of Lumi...
08/18/2025 11:04:25

The test offers results that are comparable to existing methods that support a diagnosis of Alzheimer's disease – cerebrosp...

is-the-market-bullish-or-bearish-on-labcorp-hldgs
Is the Market Bullish or Bearish on Labcor...
08/04/2025 15:00:36

labcorp-launches-test-finder-a-generative-ai-tool-developed-with-aws-to-simplify-lab-test-selection
Labcorp Launches Test Finder, A Generative...
07/30/2025 11:20:49

labcorp-secures-ivdr-ce-marking-for-first-of-its-kind-in-vitro-diagnostic-test-for-solid-tumors-in-the-eu
Labcorp Secures IVDR CE-Marking For First-...
07/29/2025 11:12:42

First-and-only test of its kind approved under new European Union regulations expands access to personalized cancer care for pa...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION